Published in J Am Coll Cardiol on February 09, 2010
Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction. Europace (2013) 0.88
Cardiac Implantable Electronic Device Infection in Patients at Risk. Arrhythm Electrophysiol Rev (2016) 0.86
Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths. Interact Cardiovasc Thorac Surg (2013) 0.82
Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction. Heart Rhythm (2010) 0.82
Management of Cardiac Electronic Device Infections: Challenges and Outcomes. Arrhythm Electrophysiol Rev (2016) 0.80
Proximal end of 15-year-old ventricular electrode penetrating pulmonary tissue - a source of infection and a challenge for transvenous lead extraction. Postepy Kardiol Interwencyjnej (2015) 0.78
Long-term outcome of complete cardiovascular implantable electronic device removal with cardiopulmonary bypass. J Artif Organs (2013) 0.78
Light in diagnosis, therapy and surgery. Nat Biomed Eng (2017) 0.75
Considerations for cardiac device lead extraction. Nat Rev Cardiol (2016) 0.75
Transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using Evolution® mechanical dilator sheath: a single center confirmatory experience. Springerplus (2016) 0.75
One-Year Follow-Up of Patients Undergoing Transvenous Extraction of Pacemaker and Defibrillator Leads. PLoS One (2015) 0.75
A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation (2015) 0.75
Lead extractions in patients with cardiac implantable electronic device infections: Single center experience. J Arrhythm (2016) 0.75
Creation of the sole regional laser lead extraction program serving Atlantic Canada: initial experience. Can J Surg (2016) 0.75
A novel use of EP catheter in extraction of trapped intracardiac devices: Two case reports. Indian Heart J (2015) 0.75
Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis: Importance of heightened awareness. World J Cardiol (2012) 0.75
High traffic congestion in right atrium. Indian Heart J (2016) 0.75
Treatment of Infected Cardiac Implantable Electronic Devices. Semin Plast Surg (2016) 0.75
Infections associated with cardiac implantable electronic devices are misunderstood. Tex Heart Inst J (2011) 0.75
Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention. Arrhythm Electrophysiol Rev (2012) 0.75
Transvenous Lead Extraction via the Inferior Approach Using a Gooseneck Snare versus Simple Manual Traction. Korean Circ J (2016) 0.75
Acute disseminated intravascular coagulation following ICD lead extraction. BMJ Case Rep (2014) 0.75
Percutaneous extraction of transvenous permanent pacemaker/defibrillator leads. Biomed Res Int (2014) 0.75
Successful pacemaker lead extraction involving an ossified thrombus: A case report. J Arrhythm (2016) 0.75
Snare sheath versus evolution sheath in transvenous lead extraction. Int J Clin Exp Med (2015) 0.75
Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol (2016) 0.75
Internal Mammary Arterial Injury from Lead Extraction: A Clinically Subtle yet Important Complication of Implantable Device Removal. Cardiol Res Pract (2011) 0.75
Lead extraction using a laser system: Techniques, efficacy, and limitations. J Arrhythm (2015) 0.75
Key Lessons from the ELECTRa Registry in the Modern Era of Transvenous Lead Extraction. Arrhythm Electrophysiol Rev (2017) 0.75
Late resolution of pacemaker lead-related severe tricuspid regurgitation and right ventricular dysfunction after percutaneous lead extraction: A case report and review of the literature. HeartRhythm Case Rep (2016) 0.75
Successful extraction of right ventricular lead remnants using the FlexCath® steerable sheath. J Interv Card Electrophysiol (2015) 0.75
[Percutaneous lead extraction : Complications and their management]. Herzschrittmacherther Elektrophysiol (2015) 0.75
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm (2009) 5.17
Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation (2010) 4.07
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 3.97
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation (2010) 3.26
Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol (2011) 2.98
Delayed lead perforation: a disturbing trend. Pacing Clin Electrophysiol (2005) 2.92
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol (2005) 2.86
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA (2010) 2.68
Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes. J Cardiovasc Electrophysiol (2013) 2.49
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm (2005) 2.43
Clinical study of the laser sheath for lead extraction: the total experience in the United States. Pacing Clin Electrophysiol (2002) 2.40
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation. J Cardiovasc Electrophysiol (2012) 2.40
Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol (2004) 2.39
Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm (2006) 2.35
Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol (2011) 2.26
Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol (2008) 2.21
Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J Am Coll Cardiol (2010) 2.12
Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm (2007) 2.01
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm (2004) 2.01
Adenosine facilitates dormant conduction across cavotricuspid isthmus following catheter ablation. Heart Rhythm (2012) 2.00
Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm (2009) 1.97
Cardiac sarcoidosis: contemporary review. J Cardiovasc Electrophysiol (2014) 1.97
Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation (2008) 1.96
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol (2009) 1.86
Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm (2008) 1.85
Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol (2013) 1.85
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol (2004) 1.83
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol (2009) 1.78
Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol (2008) 1.78
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm (2011) 1.76
Contemporary pacemakers: what the primary care physician needs to know. Mayo Clin Proc (2008) 1.75
Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2010) 1.73
Remote monitoring of cardiovascular devices: a time and activity analysis. Heart Rhythm (2012) 1.72
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. Heart Rhythm (2005) 1.67
Sustained ventricular tachycardia associated with corrective valve surgery. Circulation (2007) 1.67
Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis. Heart Rhythm (2012) 1.67
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation (2006) 1.67
Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.66
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64
Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J Am Coll Cardiol (2009) 1.64
Think before you pull--not every lead has to come out. Circ Arrhythm Electrophysiol (2010) 1.64
Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol (2003) 1.63
Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome. J Cardiovasc Electrophysiol (2008) 1.63
Hypersensitivity reactions associated with endovascular devices. Contact Dermatitis (2008) 1.63
Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol (2006) 1.61
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads. Heart Rhythm (2013) 1.61
Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design. Trials (2008) 1.60
Cardiology patient pages. Cardiac pacemakers from the patient's perspective. Circulation (2002) 1.60
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol (2003) 1.59
Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm (2007) 1.59
Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm (2010) 1.58
Percutaneous intrapericardial echocardiography during catheter ablation: a feasibility study. Heart Rhythm (2006) 1.57
Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol (2012) 1.57